EWA
NUVB icon

EverSource Wealth Advisors’s Nuvation Bio NUVB Stock Holding History

EverSource Wealth Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5K Buy
4,301
+312
+8% +$1.74K ﹤0.01% 2552
2025
Q4 		$35.7K Hold
3,989
– – ﹤0.01% 1985
2025
Q3 		$14.8K Buy
3,989
+1,771
+80% +$4.83K ﹤0.01% 2576
2025
Q2 		$4.33K Buy
2,218
+804
+57% +$1.68K ﹤0.01% 3222
2025
Q1 		$2.49K Sell
1,414
-10,010
-88% -$22.8K ﹤0.01% 2832
2024
Q4 		$30.4K Buy
11,424
+329
+3% +$847 ﹤0.01% 1407
2024
Q3 		$25.4K Hold
11,095
– – ﹤0.01% 1366
2024
Q2 		$42.5K Buy
11,095
+10,000
+913% +$30.5K ﹤0.01% 1166
2024
Q1 		$3.27K Hold
1,095
– – ﹤0.01% 2218
2023
Q4 		$1.65K Hold
1,095
– – ﹤0.01% 2229
2023
Q3 		$1.47K Sell
1,095
-1,121
-51% -$1.87K ﹤0.01% 2096
2023
Q2 		$3.99K Buy
2,216
+1,221
+123% +$2.08K ﹤0.01% 1820
2023
Q1 		$1.65K Hold
995
– – ﹤0.01% 1995
2022
Q4 		$1.91K Buy
+995
New +$2.01K ﹤0.01% 1920

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EverSource Wealth Advisors's NUVB Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Nuvation Bio (NUVB) stake by 7.8% in Q1 2026, buying an estimated $1.74K and bringing the position to 4,301 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2552.

EverSource Wealth Advisors first reported a position in NUVB in Q4 2022 and has held it in 14 quarters since. The position peaked at $42.5K in Q2 2024. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • EverSource Wealth Advisors held 4,301 shares of Nuvation Bio worth $18.5K as of Q1 2026.
  • EverSource Wealth Advisors bought 312 Nuvation Bio shares in Q1 2026, an estimated $1.74K.
  • Nuvation Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #2552 holding.
  • EverSource Wealth Advisors first reported a position in Nuvation Bio in Q4 2022 and has held it in 14 quarters since.
  • EverSource Wealth Advisors's Nuvation Bio position peaked at $42.5K in Q2 2024.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.